You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

14C-Microtracer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Healthy Participants Trial in Groningen (Oral [14C]PF-07081532, Oral PF-07081532 and IV [14C]PF-07081532)

Recruiting
  • Healthy Participants
  • Oral [14C]PF-07081532
  • Oral PF-07081532 and IV [14C]PF-07081532
  • Groningen, Netherlands
    PRA Health Sciences
Jan 5, 2023

Healthy Trial (BI 1810631 (C-14) formulation 1, BI 1810631, BI 1810631 (C-14) formulation 2)

Not yet recruiting
  • Healthy
  • BI 1810631 (C-14) formulation 1
  • +2 more
  • (no location specified)
May 25, 2023

Healthy Trial (BI 1015550, BI 1015550 mixed with [C-14]-BI 1015550)

Not yet recruiting
  • Healthy
  • BI 1015550
  • BI 1015550 mixed with [C-14]-BI 1015550
  • (no location specified)
Feb 6, 2023

Type 2 Diabetes, Healthy Subjects Trial in Nottingham (Sotagliflozin (SAR439954), 14C-microtracer, Charcoal)

Completed
  • Type 2 Diabetes Mellitus
  • Healthy Subjects
  • Sotagliflozin (SAR439954)
  • +2 more
  • Nottingham, United Kingdom
    Investigational site number 8260001
Apr 21, 2022

Healthy Volunteers Trial in Nottingham (Oral solution, [14C]BMS-986177 Solution for Infusion, BMS-986177 Spray-dried Dispersion

Completed
  • Healthy Volunteers
  • Oral solution
  • +2 more
  • Nottingham, United Kingdom
    Local Institution
Nov 11, 2021

Healthy Subjects Trial in Nottingham (Quizartinib diHCl, 14C-Quizartinib solution for infusion)

Completed
Has Results
  • Healthy Subjects
  • Quizartinib dihydrochloride
  • 14C-Quizartinib solution for infusion
  • Nottingham, United Kingdom
    Quotient Sciences
Apr 15, 2022

Sickle Cell Disease Trial in Groningen (GBT021601)

Active, not recruiting
  • Sickle Cell Disease
  • Groningen, Netherlands
    ICON Clinical Research Unit
Jan 30, 2023

Healthy Trial in Groningen (ACT-777991 (SAD), ACT-777991 (MAD), Placebo (SAD))

Completed
  • Healthy
  • ACT-777991 (SAD)
  • +7 more
  • Groningen, Netherlands
    QPS Netherlands B.V.
Jun 17, 2022

Breast Cancer, Healthy Volunteers Trial in Nottingham (amcenestrant, [14C]-SAR439859 microtracer, [14C]-SAR439859)

Completed
  • Breast Cancer
  • Healthy Volunteers
  • Nottingham, United Kingdom
    Investigational Site Number 8260001
Apr 21, 2022

Healthy Trial in Nottingham (GLPG3667 capsule, [14C]-GLPG3667 solution for infusion, [14C]-GLPG3667 capsule)

Completed
  • Healthy
  • GLPG3667 capsule
  • +2 more
  • Nottingham, United Kingdom
    Quotient Sciences Limited
Jun 29, 2022

Healthy Trial in Groningen (Enpatoran, [14C]enpatoran microtracer, [14C]enpatoran microdose)

Completed
  • Healthy
  • Groningen, Netherlands
    PRA Health Sciences
Mar 22, 2022

Other Cancer Trial in Budapest ([14C]M6620, M6620, Topotecan)

Recruiting
  • Other Cancer
  • Budapest, Hungary
  • +1 more
Jun 22, 2022

HIV Trial in London (GSK3640254 Oral tablet, [14C]-GSK3640254 intravenous infusion, [14C]-GSK3640254 powder)

Completed
Has Results
  • HIV Infections
  • GSK3640254 Oral tablet
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
Nov 19, 2021

Healthy Volunteers Trial in Baltimore (BIIB122 (DNL151), [14C] BIIB122 ([14C] DNL151))

Completed
  • Healthy Volunteers
  • BIIB122 (DNL151)
  • [14C] BIIB122 ([14C] DNL151)
  • Baltimore, Maryland
    Pharmaron CPC
Nov 9, 2021

Healthy Volunteers Trial in Madison (Acalabrutinib, Microtracer [14C]ACP-196)

Completed
  • Healthy Volunteers
  • Madison, Wisconsin
    Covance Clinical Research Unit, Inc.
May 21, 2021

Pulmonary Disease, Chronic Obstructive Trial in London ([14C]-GSK961081 solution for IV infusion, [14C]-GSK961081 oral solution,

Completed
  • Pulmonary Disease, Chronic Obstructive
  • [14C]-GSK961081 solution for IV infusion
  • +2 more
  • London, United Kingdom
    GSK Investigational Site
Sep 28, 2021

Healthy Trial in Nottingham (GLPG3970 film-coated tablet, [14C]GLPG3970 solution for infusion, [14]GLPG3970 oral solution)

Completed
  • Healthy
  • GLPG3970 film-coated tablet
  • +2 more
  • Nottingham, United Kingdom
    Quotient Sciences Ltd
Jul 22, 2021

Healthy Trial in Groningen (BI 1467335, BI 1467335 (C-14) intravenous solution)

Completed
Has Results
  • Healthy
  • BI 1467335
  • BI 1467335 (C-14) intravenous solution
  • Groningen, Netherlands
    PRA Health Sciences Onderzoekscentrum Martini
Jun 11, 2021

Healthy Trial in Seoul (LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose)

Completed
  • Healthy
  • LCB01-0371 dose with a [14C]-LCB01-0371-tracer dose
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 10, 2021

Healthy Trial in Nottingham (GLPG1205 film-coated tablets, [14C]-GLPG1205 solution for infusion, GLPG1205 capsules)

Completed
  • Healthy
  • GLPG1205 film-coated tablets
  • +2 more
  • Nottingham, United Kingdom
    Quotient Sciences
Mar 24, 2021

Opioid Use Disorder Trial ([14C]IDV184001AN)

Not yet recruiting
  • Opioid Use Disorder
  • (no location specified)
Aug 1, 2023

Healthy Subjects, Pharmacokinetics of 14C-labeled of LXI-15028 Trial in Suzhou ([14C]LXI-15028)

Completed
  • Healthy Subjects
  • Pharmacokinetics of 14C-labeled of LXI-15028
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
May 22, 2023

Lymphoma Trial ([14C]SHR2554)

Not yet recruiting
  • Lymphoma
  • (no location specified)
Aug 20, 2023

Primary Biliary Cholangitis Trial in Suzhou ([14C]CS0159)

Not yet recruiting
  • Primary Biliary Cholangitis
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Oct 18, 2023

Helicobacter Pylori Infection Trial in Suzhou ([14C]TNP-2198)

Completed
  • Helicobacter Pylori Infection
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Nov 15, 2023